Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

173 results for Pharmaceuticals
CLEAR ALL
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for pharmaceutical applications.
Actylis
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000189
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for pharmaceutical applications. It acts as a stabilizer.
Actylis
Excipient designed for pharmaceutical applications. It acts as a stabilizer.
Actylis
Excipient developed for use in pharmaceutical injections. Benefits:
  • It possesses characteristic aromatic odor
  • It complies with USP specifications